BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1515465)

  • 1. Structure-function relationships in indium-111 radioimmunoconjugates.
    Brandt KD; Johnson DK
    Bioconjug Chem; 1992; 3(2):118-25. PubMed ID: 1515465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D
    J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
    Williams LE; Lewis MR; Bebb GG; Clarke KG; Odom-Maryon TL; Shively JE; Raubitschek AA
    Bioconjug Chem; 1998; 9(1):87-93. PubMed ID: 9460550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
    Schuhmacher J; Klivényi G; Hull WE; Matys R; Hauser H; Kalthoff H; Schmiegel WH; Maier-Borst W; Matzku S
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):809-24. PubMed ID: 1428911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual isotope study of iodine-125 and indium-111-labeled antibody in athymic mice.
    Carney PL; Rogers PE; Johnson DK
    J Nucl Med; 1989 Mar; 30(3):374-84. PubMed ID: 2738666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
    Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
    J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 90Y-labeled antibody uptake by human tumor xenografts and the effect of systemic administration of EDTA.
    Rowlinson-Busza G; Snook D; Epenetos AA
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1257-65. PubMed ID: 8175414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
    Schneider DW; Heitner T; Alicke B; Light DR; McLean K; Satozawa N; Parry G; Yoo J; Lewis JS; Parry R
    J Nucl Med; 2009 Mar; 50(3):435-43. PubMed ID: 19223400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts.
    Roselli M; Milenic DE; Brechbiel MW; Mirzadeh S; Pippin CG; Gansow OA; Colcher D; Schlom J
    Cancer Biother Radiopharm; 1999 Jun; 14(3):209-20. PubMed ID: 10850305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
    Turner A; King DJ; Farnsworth AP; Rhind SK; Pedley RB; Boden J; Boden R; Millican TA; Millar K; Boyce B
    Br J Cancer; 1994 Jul; 70(1):35-41. PubMed ID: 8018538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies.
    Roselli M; Schlom J; Gansow OA; Brechbiel MW; Mirzadeh S; Pippin CG; Milenic DE; Colcher D
    Int J Rad Appl Instrum B; 1991; 18(4):389-94. PubMed ID: 1864727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of indium-111 in human malignant tumor xenografts and control by chelators.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Kim EE; Sasaki Y
    Nucl Med Biol; 1999 Oct; 26(7):853-8. PubMed ID: 10628568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
    Westerberg DA; Carney PL; Rogers PE; Kline SJ; Johnson DK
    J Med Chem; 1989 Jan; 32(1):236-43. PubMed ID: 2491892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation.
    Subramanian R; Colony J; Shaban S; Sidrak H; Haspel MV; Pomato N; Hanna MG; McCabe RP
    Bioconjug Chem; 1992; 3(3):248-55. PubMed ID: 1520729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.